CNS drug development lags far behind oncology, but translationally relevant mouse models can help close that gap and improve trial outcomes.
The post Mouse models and CRO selection critical to de-risking neurology drug development appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.
AsyncAPI Malware Contains Modules to Steal GitHub, npm, Cloud and AI API Credentials
A dangerous supply chain attack struck the AsyncAPI project on the npm registry, putting developers and automated build systems at risk. Attackers republished five package
